sur NFL BIOSCIENCES (EPA:ALNFL)
NFL Biosciences Presents NFL-101 at Tobacco Congress
NFL Biosciences unveiled the mechanisms of action of NFL-101 at the annual meeting of the Société Francophone de Tabalogie. This innovative drug candidate is intended for smoking cessation. It is distinguished by a disruptive mechanism that could favorably impact smoking cessation.
The mechanism under study could offer smokers an effective alternative. NFL Biosciences demonstrates its continued commitment to the development of novel therapeutic solutions. The clinical efficacy of NFL-101 and its safety profile are currently being tested at the clinical scale.
The congress provided an ideal platform for the society to share its recent scientific advances. This presentation could mark a turning point in the treatment of tobacco use using innovative therapies.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NFL BIOSCIENCES